Prophylactic Azithromycin Therapy After Lung Transplantation: Post hoc Analysis of a Randomized Controlled Trial
Open Access
- 1 January 2016
- journal article
- research article
- Published by Elsevier in American Journal of Transplantation
- Vol. 16 (1) , 254-261
Abstract
No abstract availableKeywords
Funding Information
- Fonds Wetenschappelijk Onderzoek (KAN2014 1.5.139.14, 12G 8715N, G.0723.10, G.0679.12, G.0679.12, G.3C04.99)
This publication has 25 references indexed in Scilit:
- A randomised controlled trial of azithromycin therapy in bronchiolitis obliterans syndrome (BOS) post lung transplantationThorax, 2015
- An international ISHLT/ATS/ERS clinical practice guideline: diagnosis and management of bronchiolitis obliterans syndromeEuropean Respiratory Journal, 2014
- The Registry of the International Society for Heart and Lung Transplantation: Thirty-first Adult Lung and Heart–Lung Transplant Report—2014; Focus Theme: RetransplantationThe Journal of Heart and Lung Transplantation, 2014
- A new classification system for chronic lung allograft dysfunctionThe Journal of Heart and Lung Transplantation, 2014
- Long-term azithromycin therapy for bronchiolitis obliterans syndrome: Divide and conquer?The Journal of Heart and Lung Transplantation, 2010
- A dichotomy in bronchiolitis obliterans syndrome after lung transplantation revealed by azithromycin therapyEuropean Respiratory Journal, 2008
- Long-Term Azithromycin for Bronchiolitis Obliterans Syndrome After Lung TransplantationTransplantation, 2008
- Azithromycin Reduces Airway Neutrophilia and Interleukin-8 in Patients with Bronchiolitis Obliterans SyndromeAmerican Journal of Respiratory and Critical Care Medicine, 2006
- AZITHROMYCIN THERAPY FOR PATIENTS WITH BRONCHIOLITIS OBLITERANS SYNDROME AFTER LUNG TRANSPLANTATIONTransplantation, 2004
- Maintenance Azithromycin Therapy for Bronchiolitis Obliterans SyndromeAmerican Journal of Respiratory and Critical Care Medicine, 2003